TheProfitWatch

LVTX - LAVA Therapeutics N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
--- --- --- --- --- --- --- ---

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.13
Diluted EPS:
-0.13
Basic P/E:
Diluted P/E:
RSI(14) 1m:
92.86
VWAP:
1.77
RVol:

Events

Period Kind Movement Occurred At

Related News